id	sid	tid	token	lemma	pos
cajgh-103	1	1	biopharmaceutical	biopharmaceutical	ADJ
cajgh-103	1	2	characteristics	characteristic	NOUN
cajgh-103	1	3	of	of	ADP
cajgh-103	1	4	autologous	autologous	ADJ
cajgh-103	1	5	red	red	ADJ
cajgh-103	1	6	blood	blood	NOUN
cajgh-103	1	7	cells	cell	NOUN
cajgh-103	1	8	ghosts	ghost	NOUN
cajgh-103	1	9	containing	contain	VERB
cajgh-103	1	10	cytokines	cytokine	NOUN
cajgh-103	1	11	and	and	CCONJ
cajgh-103	1	12	antibiotics	antibiotic	NOUN
cajgh-103	1	13	new	new	ADJ
cajgh-103	1	14	articles	article	NOUN
cajgh-103	1	15	in	in	ADP
cajgh-103	1	16	this	this	DET
cajgh-103	1	17	journal	journal	NOUN
cajgh-103	1	18	are	be	AUX
cajgh-103	1	19	licensed	license	VERB
cajgh-103	1	20	under	under	ADP
cajgh-103	1	21	a	a	DET
cajgh-103	1	22	creative	creative	ADJ
cajgh-103	1	23	commons	common	NOUN
cajgh-103	1	24	attribution	attribution	NOUN
cajgh-103	1	25	3.0	3.0	NUM
cajgh-103	1	26	united	unite	VERB
cajgh-103	1	27	states	states	PROPN
cajgh-103	1	28	license	license	NOUN
cajgh-103	1	29	.	.	PUNCT
cajgh-103	2	1	this	this	DET
cajgh-103	2	2	journal	journal	NOUN
cajgh-103	2	3	is	be	AUX
cajgh-103	2	4	published	publish	VERB
cajgh-103	2	5	by	by	ADP
cajgh-103	2	6	the	the	DET
cajgh-103	2	7	university	university	NOUN
cajgh-103	2	8	library	library	NOUN
cajgh-103	2	9	system	system	NOUN
cajgh-103	2	10	of	of	ADP
cajgh-103	2	11	the	the	DET
cajgh-103	2	12	university	university	PROPN
cajgh-103	2	13	of	of	ADP
cajgh-103	2	14	pittsburgh	pittsburgh	PROPN
cajgh-103	2	15	as	as	ADP
cajgh-103	2	16	part	part	NOUN
cajgh-103	2	17	of	of	ADP
cajgh-103	2	18	its	its	PRON
cajgh-103	2	19	d	d	NOUN
cajgh-103	2	20	-	-	PUNCT
cajgh-103	2	21	scribe	scribe	VERB
cajgh-103	2	22	digital	digital	ADJ
cajgh-103	2	23	publishing	publishing	NOUN
cajgh-103	2	24	program	program	NOUN
cajgh-103	2	25	and	and	CCONJ
cajgh-103	2	26	is	be	AUX
cajgh-103	2	27	cosponsored	cosponsor	VERB
cajgh-103	2	28	by	by	ADP
cajgh-103	2	29	the	the	DET
cajgh-103	2	30	university	university	PROPN
cajgh-103	2	31	of	of	ADP
cajgh-103	2	32	pittsburgh	pittsburgh	PROPN
cajgh-103	2	33	press	press	NOUN
cajgh-103	2	34	.	.	PUNCT
cajgh-103	3	1	biopharmaceutical	biopharmaceutical	ADJ
cajgh-103	3	2	characteristics	characteristic	NOUN
cajgh-103	3	3	of	of	ADP
cajgh-103	3	4	autologous	autologous	ADJ
cajgh-103	3	5	red	red	ADJ
cajgh-103	3	6	blood	blood	NOUN
cajgh-103	3	7	cells	cell	NOUN
cajgh-103	3	8	ghosts	ghost	NOUN
cajgh-103	3	9	containing	contain	VERB
cajgh-103	3	10	cytokines	cytokine	NOUN
cajgh-103	3	11	and	and	CCONJ
cajgh-103	3	12	antibiotics	antibiotic	NOUN
cajgh-103	3	13	zhaxybay	zhaxybay	VERB
cajgh-103	3	14	zhumadilov1	zhumadilov1	PROPN
cajgh-103	3	15	,	,	PUNCT
cajgh-103	3	16	kulzhan	kulzhan	ADJ
cajgh-103	3	17	berikkhanova1	berikkhanova1	PROPN
cajgh-103	3	18	,	,	PUNCT
cajgh-103	3	19	zarina	zarina	PROPN
cajgh-103	3	20	shulgau1	shulgau1	PROPN
cajgh-103	3	21	,	,	PUNCT
cajgh-103	3	22	alexander	alexander	PROPN
cajgh-103	3	23	gulyayev1	gulyayev1	PROPN
cajgh-103	3	24	,	,	PUNCT
cajgh-103	3	25	zanybek	zanybek	ADJ
cajgh-103	3	26	bokebayev2	bokebayev2	NOUN
cajgh-103	3	27	,	,	PUNCT
cajgh-103	3	28	nadiyar	nadiyar	PROPN
cajgh-103	3	29	mussin2	mussin2	NOUN
cajgh-103	3	30	,	,	PUNCT
cajgh-103	3	31	talgat	talgat	ADJ
cajgh-103	3	32	nurgozhin1	nurgozhin1	ADJ
cajgh-103	3	33	1center	1center	NUM
cajgh-103	3	34	for	for	ADP
cajgh-103	3	35	life	life	NOUN
cajgh-103	3	36	sciences	science	NOUN
cajgh-103	3	37	,	,	PUNCT
cajgh-103	3	38	nazarbayev	nazarbayev	ADJ
cajgh-103	3	39	university	university	NOUN
cajgh-103	3	40	,	,	PUNCT
cajgh-103	3	41	astana	astana	PROPN
cajgh-103	3	42	,	,	PUNCT
cajgh-103	3	43	kazakhstan	kazakhstan	PROPN
cajgh-103	3	44	;	;	PUNCT
cajgh-103	3	45	2astana	2astana	NUM
cajgh-103	3	46	medical	medical	ADJ
cajgh-103	3	47	university	university	NOUN
cajgh-103	3	48	,	,	PUNCT
cajgh-103	3	49	astana	astana	PROPN
cajgh-103	3	50	,	,	PUNCT
cajgh-103	3	51	kazakhstan	kazakhstan	PROPN
cajgh-103	3	52	vol	vol	NOUN
cajgh-103	3	53	.	.	PROPN
cajgh-103	4	1	2	2	NUM
cajgh-103	4	2	,	,	PUNCT
cajgh-103	4	3	suppl	suppl	ADJ
cajgh-103	4	4	.	.	PUNCT
cajgh-103	5	1	(	(	PUNCT
cajgh-103	5	2	2013	2013	NUM
cajgh-103	5	3	)	)	PUNCT
cajgh-103	5	4	|	|	ADV
cajgh-103	5	5	issn	issn	VERB
cajgh-103	5	6	2166	2166	NUM
cajgh-103	5	7	-	-	SYM
cajgh-103	5	8	7403	7403	NUM
cajgh-103	5	9	(	(	PUNCT
cajgh-103	5	10	online	online	ADJ
cajgh-103	5	11	)	)	PUNCT
cajgh-103	5	12	doi	doi	NOUN
cajgh-103	5	13	10.5195	10.5195	NUM
cajgh-103	5	14	/	/	SYM
cajgh-103	5	15	cajgh.2013.103	cajgh.2013.103	NOUN
cajgh-103	5	16	|	|	ADV
cajgh-103	5	17	http://cajgh.pitt.edu	http://cajgh.pitt.edu	VERB
cajgh-103	5	18	http://www.library.pitt.edu/	http://www.library.pitt.edu/	PROPN
cajgh-103	5	19	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-103	5	20	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	X
cajgh-103	6	1	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	PRON
cajgh-103	6	2	http://creativecommons.org/licenses/by/3.0/us/	http://creativecommons.org/licenses/by/3.0/us/	NOUN
cajgh-103	6	3	zhumadilov	zhumadilov	NOUN
cajgh-103	6	4	this	this	DET
cajgh-103	6	5	work	work	NOUN
cajgh-103	6	6	is	be	AUX
cajgh-103	6	7	licensed	license	VERB
cajgh-103	6	8	under	under	ADP
cajgh-103	6	9	a	a	DET
cajgh-103	6	10	creative	creative	ADJ
cajgh-103	6	11	commons	common	NOUN
cajgh-103	6	12	attribution	attribution	NOUN
cajgh-103	6	13	3.0	3.0	NUM
cajgh-103	6	14	united	unite	VERB
cajgh-103	6	15	states	states	PROPN
cajgh-103	6	16	license	license	NOUN
cajgh-103	6	17	.	.	PUNCT
cajgh-103	7	1	this	this	DET
cajgh-103	7	2	journal	journal	NOUN
cajgh-103	7	3	is	be	AUX
cajgh-103	7	4	published	publish	VERB
cajgh-103	7	5	by	by	ADP
cajgh-103	7	6	the	the	DET
cajgh-103	7	7	university	university	NOUN
cajgh-103	7	8	library	library	NOUN
cajgh-103	7	9	system	system	NOUN
cajgh-103	7	10	of	of	ADP
cajgh-103	7	11	the	the	DET
cajgh-103	7	12	university	university	PROPN
cajgh-103	7	13	of	of	ADP
cajgh-103	7	14	pittsburgh	pittsburgh	PROPN
cajgh-103	7	15	as	as	ADP
cajgh-103	7	16	part	part	NOUN
cajgh-103	7	17	of	of	ADP
cajgh-103	7	18	its	its	PRON
cajgh-103	7	19	d	d	NOUN
cajgh-103	7	20	-	-	PUNCT
cajgh-103	7	21	scribe	scribe	VERB
cajgh-103	7	22	digital	digital	ADJ
cajgh-103	7	23	publishing	publishing	NOUN
cajgh-103	7	24	program	program	NOUN
cajgh-103	7	25	and	and	CCONJ
cajgh-103	7	26	is	be	AUX
cajgh-103	7	27	cosponsored	cosponsor	VERB
cajgh-103	7	28	by	by	ADP
cajgh-103	7	29	the	the	DET
cajgh-103	7	30	university	university	PROPN
cajgh-103	7	31	of	of	ADP
cajgh-103	7	32	pittsburgh	pittsburgh	PROPN
cajgh-103	7	33	press	press	NOUN
cajgh-103	7	34	.	.	PUNCT
cajgh-103	8	1	central	central	ADJ
cajgh-103	8	2	asian	asian	ADJ
cajgh-103	8	3	journal	journal	NOUN
cajgh-103	8	4	of	of	ADP
cajgh-103	8	5	global	global	ADJ
cajgh-103	8	6	health	health	NOUN
cajgh-103	8	7	volume	volume	NOUN
cajgh-103	8	8	2	2	NUM
cajgh-103	8	9	,	,	PUNCT
cajgh-103	8	10	suppl	suppl	ADJ
cajgh-103	8	11	.	.	PUNCT
cajgh-103	9	1	(	(	PUNCT
cajgh-103	9	2	2013	2013	NUM
cajgh-103	9	3	)	)	PUNCT
cajgh-103	9	4	|	|	ADV
cajgh-103	9	5	issn	issn	VERB
cajgh-103	9	6	2166	2166	NUM
cajgh-103	9	7	-	-	SYM
cajgh-103	9	8	7403	7403	NUM
cajgh-103	9	9	(	(	PUNCT
cajgh-103	9	10	online	online	ADJ
cajgh-103	9	11	)	)	PUNCT
cajgh-103	9	12	|	|	ADV
cajgh-103	9	13	doi	doi	X
cajgh-103	9	14	10.5195	10.5195	NUM
cajgh-103	9	15	/	/	SYM
cajgh-103	9	16	cajgh.2013.103	cajgh.2013.103	NOUN
cajgh-103	10	1	|	|	NOUN
cajgh-103	10	2	http://cajgh.pitt.edu	http://cajgh.pitt.edu	VERB
cajgh-103	10	3	abstract	abstract	ADJ
cajgh-103	10	4	introduction	introduction	NOUN
cajgh-103	10	5	:	:	PUNCT
cajgh-103	10	6	transport	transport	NOUN
cajgh-103	10	7	systems	system	NOUN
cajgh-103	10	8	based	base	VERB
cajgh-103	10	9	on	on	ADP
cajgh-103	10	10	autologous	autologous	ADJ
cajgh-103	10	11	red	red	ADJ
cajgh-103	10	12	blood	blood	NOUN
cajgh-103	10	13	cells	cell	NOUN
cajgh-103	10	14	for	for	ADP
cajgh-103	10	15	targeted	target	VERB
cajgh-103	10	16	drug	drug	NOUN
cajgh-103	10	17	delivery	delivery	NOUN
cajgh-103	10	18	can	can	AUX
cajgh-103	10	19	be	be	AUX
cajgh-103	10	20	considered	consider	VERB
cajgh-103	10	21	as	as	ADP
cajgh-103	10	22	a	a	DET
cajgh-103	10	23	promising	promising	ADJ
cajgh-103	10	24	approach	approach	NOUN
cajgh-103	10	25	in	in	ADP
cajgh-103	10	26	the	the	DET
cajgh-103	10	27	treatment	treatment	NOUN
cajgh-103	10	28	of	of	ADP
cajgh-103	10	29	surgical	surgical	ADJ
cajgh-103	10	30	infections	infection	NOUN
cajgh-103	10	31	.	.	PUNCT
cajgh-103	11	1	experimental	experimental	ADJ
cajgh-103	11	2	studies	study	NOUN
cajgh-103	11	3	have	have	AUX
cajgh-103	11	4	revealed	reveal	VERB
cajgh-103	11	5	the	the	DET
cajgh-103	11	6	feasibility	feasibility	NOUN
cajgh-103	11	7	of	of	ADP
cajgh-103	11	8	targeted	target	VERB
cajgh-103	11	9	drug	drug	NOUN
cajgh-103	11	10	delivery	delivery	NOUN
cajgh-103	11	11	by	by	ADP
cajgh-103	11	12	encapsulation	encapsulation	NOUN
cajgh-103	11	13	of	of	ADP
cajgh-103	11	14	cytokines	cytokine	NOUN
cajgh-103	11	15	and	and	CCONJ
cajgh-103	11	16	antibiotics	antibiotic	NOUN
cajgh-103	11	17	into	into	ADP
cajgh-103	11	18	autologous	autologous	ADJ
cajgh-103	11	19	erythrocyte	erythrocyte	NOUN
cajgh-103	11	20	ghosts	ghost	NOUN
cajgh-103	11	21	.	.	PUNCT
cajgh-103	12	1	purpose	purpose	NOUN
cajgh-103	12	2	:	:	PUNCT
cajgh-103	12	3	to	to	PART
cajgh-103	12	4	study	study	VERB
cajgh-103	12	5	biopharmaceutical	biopharmaceutical	ADJ
cajgh-103	12	6	characteristics	characteristic	NOUN
cajgh-103	12	7	of	of	ADP
cajgh-103	12	8	autologous	autologous	ADJ
cajgh-103	12	9	erythrocyte	erythrocyte	NOUN
cajgh-103	12	10	ghosts	ghost	NOUN
cajgh-103	12	11	containing	contain	VERB
cajgh-103	12	12	cytokines	cytokine	NOUN
cajgh-103	12	13	and	and	CCONJ
cajgh-103	12	14	antibiotics	antibiotic	NOUN
cajgh-103	12	15	(	(	PUNCT
cajgh-103	12	16	pharmacocytes	pharmacocyte	NOUN
cajgh-103	12	17	)	)	PUNCT
cajgh-103	12	18	.	.	PUNCT
cajgh-103	13	1	material	material	NOUN
cajgh-103	13	2	and	and	CCONJ
cajgh-103	13	3	methods	method	NOUN
cajgh-103	13	4	:	:	PUNCT
cajgh-103	13	5	the	the	DET
cajgh-103	13	6	erythrocyte	erythrocyte	NOUN
cajgh-103	13	7	pharmacocytes	pharmacocyte	NOUN
cajgh-103	13	8	were	be	AUX
cajgh-103	13	9	prepared	prepare	VERB
cajgh-103	13	10	by	by	ADP
cajgh-103	13	11	the	the	DET
cajgh-103	13	12	hypotonic	hypotonic	ADJ
cajgh-103	13	13	hemolysis	hemolysis	NOUN
cajgh-103	13	14	method	method	NOUN
cajgh-103	13	15	,	,	PUNCT
cajgh-103	13	16	or	or	CCONJ
cajgh-103	13	17	the	the	DET
cajgh-103	13	18	use	use	NOUN
cajgh-103	13	19	of	of	ADP
cajgh-103	13	20	human	human	ADJ
cajgh-103	13	21	red	red	ADJ
cajgh-103	13	22	blood	blood	NOUN
cajgh-103	13	23	cells	cell	NOUN
cajgh-103	13	24	.	.	PUNCT
cajgh-103	14	1	the	the	DET
cajgh-103	14	2	association	association	NOUN
cajgh-103	14	3	and	and	CCONJ
cajgh-103	14	4	dissociation	dissociation	NOUN
cajgh-103	14	5	indicators	indicator	NOUN
cajgh-103	14	6	of	of	ADP
cajgh-103	14	7	rifampicin	rifampicin	VERB
cajgh-103	14	8	and	and	CCONJ
cajgh-103	14	9	cytokine	cytokine	VERB
cajgh-103	14	10	substances	substance	NOUN
cajgh-103	14	11	with	with	ADP
cajgh-103	14	12	the	the	DET
cajgh-103	14	13	erythrocyte	erythrocyte	NOUN
cajgh-103	14	14	ghosts	ghost	NOUN
cajgh-103	14	15	were	be	AUX
cajgh-103	14	16	conducted	conduct	VERB
cajgh-103	14	17	using	use	VERB
cajgh-103	14	18	standard	standard	ADJ
cajgh-103	14	19	methods	method	NOUN
cajgh-103	14	20	.	.	PUNCT
cajgh-103	15	1	results	result	NOUN
cajgh-103	15	2	:	:	PUNCT
cajgh-103	15	3	we	we	PRON
cajgh-103	15	4	have	have	AUX
cajgh-103	15	5	defined	define	VERB
cajgh-103	15	6	the	the	DET
cajgh-103	15	7	following	follow	VERB
cajgh-103	15	8	extracellular	extracellular	ADJ
cajgh-103	15	9	concentrations	concentration	NOUN
cajgh-103	15	10	to	to	PART
cajgh-103	15	11	be	be	AUX
cajgh-103	15	12	optimal	optimal	ADJ
cajgh-103	15	13	for	for	ADP
cajgh-103	15	14	deposition	deposition	NOUN
cajgh-103	15	15	of	of	ADP
cajgh-103	15	16	drug	drug	NOUN
cajgh-103	15	17	substances	substance	NOUN
cajgh-103	15	18	into	into	ADP
cajgh-103	15	19	pharmacocytes	pharmacocyte	NOUN
cajgh-103	15	20	:	:	PUNCT
cajgh-103	15	21	for	for	ADP
cajgh-103	15	22	rifampicin	rifampicin	VERB
cajgh-103	15	23	–	–	PUNCT
cajgh-103	15	24	10	10	NUM
cajgh-103	15	25	000	000	NUM
cajgh-103	15	26	μ	μ	NUM
cajgh-103	15	27	/	/	SYM
cajgh-103	15	28	ml	ml	ADJ
cajgh-103	15	29	,	,	PUNCT
cajgh-103	15	30	erythropoietin	erythropoietin	VERB
cajgh-103	15	31	1000	1000	NUM
cajgh-103	15	32	iu	iu	ADP
cajgh-103	15	33	/	/	SYM
cajgh-103	15	34	ml	ml	PROPN
cajgh-103	15	35	,	,	PUNCT
cajgh-103	15	36	tnf	tnf	PROPN
cajgh-103	15	37	-	-	PUNCT
cajgh-103	15	38	a	a	DET
cajgh-103	15	39	5000	5000	NUM
cajgh-103	15	40	iu	iu	ADP
cajgh-103	15	41	/	/	SYM
cajgh-103	15	42	ml	ml	NOUN
cajgh-103	15	43	,	,	PUNCT
cajgh-103	15	44	il-1	il-1	PROPN
cajgh-103	15	45	-	-	PUNCT
cajgh-103	15	46	β	β	NOUN
cajgh-103	15	47	5000	5000	NUM
cajgh-103	15	48	u	u	NOUN
cajgh-103	15	49	/	/	SYM
cajgh-103	15	50	ml	ml	PROPN
cajgh-103	15	51	,	,	PUNCT
cajgh-103	15	52	ifn	ifn	PROPN
cajgh-103	15	53	-	-	PUNCT
cajgh-103	15	54	γ	γ	X
cajgh-103	15	55	10	10	NUM
cajgh-103	15	56	000me	000me	NOUN
cajgh-103	15	57	/	/	PUNCT
cajgh-103	16	1	ml	ml	ADP
cajgh-103	16	2	,	,	PUNCT
cajgh-103	16	3	il-2	il-2	PROPN
cajgh-103	16	4	50	50	NUM
cajgh-103	16	5	000	000	NUM
cajgh-103	16	6	iu	iu	ADP
cajgh-103	16	7	/	/	PUNCT
cajgh-103	16	8	ml	ml	NOUN
cajgh-103	16	9	,	,	PUNCT
cajgh-103	16	10	angiogenin	angiogenin	NOUN
cajgh-103	16	11	0.04	0.04	NUM
cajgh-103	16	12	mg	mg	PROPN
cajgh-103	16	13	/	/	SYM
cajgh-103	16	14	ml	ml	NOUN
cajgh-103	16	15	.	.	PUNCT
cajgh-103	17	1	two	two	NUM
cajgh-103	17	2	types	type	NOUN
cajgh-103	17	3	of	of	ADP
cajgh-103	17	4	correlations	correlation	NOUN
cajgh-103	17	5	of	of	ADP
cajgh-103	17	6	cytokines	cytokine	NOUN
cajgh-103	17	7	and	and	CCONJ
cajgh-103	17	8	pharmacocytes	pharmacocyte	NOUN
cajgh-103	17	9	were	be	AUX
cajgh-103	17	10	identified	identify	VERB
cajgh-103	17	11	.	.	PUNCT
cajgh-103	18	1	in	in	ADP
cajgh-103	18	2	this	this	DET
cajgh-103	18	3	study	study	NOUN
cajgh-103	18	4	,	,	PUNCT
cajgh-103	18	5	we	we	PRON
cajgh-103	18	6	found	find	VERB
cajgh-103	18	7	that	that	SCONJ
cajgh-103	18	8	40	40	NUM
cajgh-103	18	9	-	-	SYM
cajgh-103	18	10	60	60	NUM
cajgh-103	18	11	%	%	NOUN
cajgh-103	18	12	of	of	ADP
cajgh-103	18	13	the	the	DET
cajgh-103	18	14	erythropoietin	erythropoietin	NOUN
cajgh-103	18	15	,	,	PUNCT
cajgh-103	18	16	ifnγ	ifnγ	NOUN
cajgh-103	18	17	and	and	CCONJ
cajgh-103	18	18	angiogenin	angiogenin	NOUN
cajgh-103	18	19	were	be	AUX
cajgh-103	18	20	bound	bind	VERB
cajgh-103	18	21	to	to	ADP
cajgh-103	18	22	red	red	ADJ
cajgh-103	18	23	blood	blood	NOUN
cajgh-103	18	24	cells	cell	NOUN
cajgh-103	18	25	ghosts	ghost	NOUN
cajgh-103	18	26	,	,	PUNCT
cajgh-103	18	27	more	more	ADJ
cajgh-103	18	28	than	than	ADP
cajgh-103	18	29	10	10	NUM
cajgh-103	18	30	%	%	NOUN
cajgh-103	18	31	of	of	ADP
cajgh-103	18	32	which	which	PRON
cajgh-103	18	33	were	be	AUX
cajgh-103	18	34	bound	bind	VERB
cajgh-103	18	35	irreversibly	irreversibly	ADV
cajgh-103	18	36	.	.	PUNCT
cajgh-103	19	1	for	for	ADP
cajgh-103	19	2	tnf	tnf	PROPN
cajgh-103	19	3	-	-	PUNCT
cajgh-103	19	4	a	a	PROPN
cajgh-103	19	5	,	,	PUNCT
cajgh-103	19	6	il-1	il-1	NOUN
cajgh-103	19	7	-	-	PUNCT
cajgh-103	19	8	β	β	X
cajgh-103	19	9	and	and	CCONJ
cajgh-103	19	10	il-2	il-2	PROPN
cajgh-103	19	11	,	,	PUNCT
cajgh-103	19	12	the	the	DET
cajgh-103	19	13	red	red	ADJ
cajgh-103	19	14	blood	blood	NOUN
cajgh-103	19	15	cells	cell	NOUN
cajgh-103	19	16	ghosts	ghost	NOUN
cajgh-103	19	17	were	be	AUX
cajgh-103	19	18	capable	capable	ADJ
cajgh-103	19	19	of	of	ADP
cajgh-103	19	20	binding	bind	VERB
cajgh-103	19	21	and	and	CCONJ
cajgh-103	19	22	depositing	deposit	VERB
cajgh-103	19	23	within	within	ADP
cajgh-103	19	24	10	10	NUM
cajgh-103	19	25	-	-	SYM
cajgh-103	19	26	20	20	NUM
cajgh-103	19	27	%	%	NOUN
cajgh-103	19	28	of	of	ADP
cajgh-103	19	29	the	the	DET
cajgh-103	19	30	input	input	NOUN
cajgh-103	19	31	extracellular	extracellular	ADJ
cajgh-103	19	32	concentration	concentration	NOUN
cajgh-103	19	33	,	,	PUNCT
cajgh-103	19	34	and	and	CCONJ
cajgh-103	19	35	these	these	DET
cajgh-103	19	36	bindings	binding	NOUN
cajgh-103	19	37	were	be	AUX
cajgh-103	19	38	almost	almost	ADV
cajgh-103	19	39	completely	completely	ADV
cajgh-103	19	40	reversible	reversible	ADJ
cajgh-103	19	41	.	.	PUNCT
cajgh-103	20	1	the	the	DET
cajgh-103	20	2	rifampicin	rifampicin	PROPN
cajgh-103	20	3	was	be	AUX
cajgh-103	20	4	bound	bind	VERB
cajgh-103	20	5	by	by	ADP
cajgh-103	20	6	red	red	ADJ
cajgh-103	20	7	blood	blood	NOUN
cajgh-103	20	8	cells	cell	NOUN
cajgh-103	20	9	ghosts	ghost	NOUN
cajgh-103	20	10	with	with	ADP
cajgh-103	20	11	5	5	NUM
cajgh-103	20	12	%	%	NOUN
cajgh-103	20	13	efficiency	efficiency	NOUN
cajgh-103	20	14	and	and	CCONJ
cajgh-103	20	15	also	also	ADV
cajgh-103	20	16	completely	completely	ADV
cajgh-103	20	17	reversibly	reversibly	ADV
cajgh-103	20	18	.	.	PUNCT
cajgh-103	21	1	conclusion	conclusion	NOUN
cajgh-103	21	2	:	:	PUNCT
cajgh-103	21	3	the	the	DET
cajgh-103	21	4	study	study	NOUN
cajgh-103	21	5	has	have	AUX
cajgh-103	21	6	shown	show	VERB
cajgh-103	21	7	the	the	DET
cajgh-103	21	8	effectiveness	effectiveness	NOUN
cajgh-103	21	9	of	of	ADP
cajgh-103	21	10	inclusion	inclusion	NOUN
cajgh-103	21	11	of	of	ADP
cajgh-103	21	12	the	the	DET
cajgh-103	21	13	studied	study	VERB
cajgh-103	21	14	components	component	NOUN
cajgh-103	21	15	,	,	PUNCT
cajgh-103	21	16	such	such	ADJ
cajgh-103	21	17	as	as	ADP
cajgh-103	21	18	erythropoietin	erythropoietin	NOUN
cajgh-103	21	19	,	,	PUNCT
cajgh-103	21	20	ifn	ifn	PROPN
cajgh-103	21	21	-	-	PUNCT
cajgh-103	21	22	γ	γ	NOUN
cajgh-103	21	23	and	and	CCONJ
cajgh-103	21	24	angiogenin	angiogenin	NOUN
cajgh-103	21	25	into	into	ADP
cajgh-103	21	26	the	the	DET
cajgh-103	21	27	red	red	ADJ
cajgh-103	21	28	blood	blood	NOUN
cajgh-103	21	29	cells	cell	NOUN
cajgh-103	21	30	ghosts	ghost	NOUN
cajgh-103	21	31	,	,	PUNCT
cajgh-103	21	32	with	with	ADP
cajgh-103	21	33	significant	significant	ADJ
cajgh-103	21	34	efficiency	efficiency	NOUN
cajgh-103	21	35	(	(	PUNCT
cajgh-103	21	36	40	40	NUM
cajgh-103	21	37	-	-	SYM
cajgh-103	21	38	60	60	NUM
cajgh-103	21	39	%	%	NOUN
cajgh-103	21	40	)	)	PUNCT
cajgh-103	21	41	.	.	PUNCT
cajgh-103	22	1	it	it	PRON
cajgh-103	22	2	presents	present	VERB
cajgh-103	22	3	the	the	DET
cajgh-103	22	4	potential	potential	NOUN
cajgh-103	22	5	of	of	ADP
cajgh-103	22	6	using	use	VERB
cajgh-103	22	7	this	this	DET
cajgh-103	22	8	system	system	NOUN
cajgh-103	22	9	in	in	ADP
cajgh-103	22	10	targeted	target	VERB
cajgh-103	22	11	delivery	delivery	NOUN
cajgh-103	22	12	of	of	ADP
cajgh-103	22	13	cytokines	cytokine	NOUN
cajgh-103	22	14	and	and	CCONJ
cajgh-103	22	15	antibiotics	antibiotic	NOUN
cajgh-103	22	16	for	for	ADP
cajgh-103	22	17	treatment	treatment	NOUN
cajgh-103	22	18	of	of	ADP
cajgh-103	22	19	surgical	surgical	ADJ
cajgh-103	22	20	infections	infection	NOUN
cajgh-103	22	21	,	,	PUNCT
cajgh-103	22	22	thus	thus	ADV
cajgh-103	22	23	facilitating	facilitate	VERB
cajgh-103	22	24	the	the	DET
cajgh-103	22	25	reduction	reduction	NOUN
cajgh-103	22	26	in	in	ADP
cajgh-103	22	27	toxicity	toxicity	NOUN
cajgh-103	22	28	and	and	CCONJ
cajgh-103	22	29	adverse	adverse	ADJ
cajgh-103	22	30	systemic	systemic	ADJ
cajgh-103	22	31	effects	effect	NOUN
cajgh-103	22	32	of	of	ADP
cajgh-103	22	33	drugs	drug	NOUN
cajgh-103	22	34	and	and	CCONJ
cajgh-103	22	35	improving	improve	VERB
cajgh-103	22	36	the	the	DET
cajgh-103	22	37	treatment	treatment	NOUN
cajgh-103	22	38	results	result	NOUN
cajgh-103	22	39	.	.	PUNCT
cajgh-103	23	1	keywords	keyword	NOUN
cajgh-103	23	2	:	:	PUNCT
cajgh-103	23	3	autologous	autologous	ADJ
cajgh-103	23	4	red	red	ADJ
cajgh-103	23	5	blood	blood	NOUN
cajgh-103	23	6	cells	cell	NOUN
cajgh-103	23	7	,	,	PUNCT
cajgh-103	23	8	cytokines	cytokine	NOUN
cajgh-103	23	9	,	,	PUNCT
cajgh-103	23	10	antibiotics	antibiotic	NOUN
cajgh-103	23	11	http://www.library.pitt.edu/	http://www.library.pitt.edu/	NOUN
cajgh-103	23	12	http://www.pitt.edu/	http://www.pitt.edu/	NOUN
cajgh-103	23	13	http://www.library.pitt.edu/articles/digpubtype/index.html	http://www.library.pitt.edu/articles/digpubtype/index.html	PUNCT
cajgh-103	24	1	http://www.upress.pitt.edu/upressindex.aspx	http://www.upress.pitt.edu/upressindex.aspx	NOUN